Importantly, CD133 knockdown increased the survival of tumor‐bearing mice, which was fully restored by expression of shRNA‐resistant wild‐type CD133, but not by the shRNA‐resistant CD133(1–862) mutant (Figure 5D–G). This evidence concerns the gene PROM1 and neoplasm.